ロード中...
Immuno-PET imaging of the hepatocyte growth factor receptor Met using the one-armed antibody Onartuzumab (MetMAb)
The over-expression and -activation of hepatocyte growth factor receptor (Met) in various cancers has been linked to increased proliferation, progression to metastatic disease, and drug resistance. Developing a PET imaging agent to assess Met expression would aid in diagnosis and monitoring response...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3982858/ https://ncbi.nlm.nih.gov/pubmed/22917884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.111.102293 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|